Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease

Magnetic Resonance in Medicine

Volumn 53, Issue 3, 2005, Pages 607-613

  Vanhoutte, Greetje ^a   Dewachter, I ^b   Borghgraef, P ^b   Van Leuven, F ^b   Van Der Linden, A ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Alzheimer's disease; Amyloid plaques; In vivo MRI; Iron; Mouse

Indexed keywords

GLYCOPROTEINS; IRON; MAMMALS; NEURODEGENERATIVE DISEASES;

ALZHEIMER'S DISEASE; AMYLOID PLAQUES; AMYLOID PRECURSOR PROTEINS; IN-VIVO; MOUSE; RESEARCH OPPORTUNITIES; STAINING TECHNIQUES; TRANSGENIC MICE;

MAGNETIC RESONANCE IMAGING;

AMYLOID PRECURSOR PROTEIN; IRON;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMAGE ANALYSIS; IN VIVO STUDY; MOUSE; NEURITIC PLAQUE; NEUROPATHOLOGY; NEUROPATHY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STAINING; THALAMUS; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE;

EID: 14744298662     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20385     Document Type: Article

References (37)

1. Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Naito M, Matsubara E, Abe K, Nakazato Y. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Virchows Arch 2002;441:358-367.
2. Cai XD, Golde TE, Younkin SG. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 1993;259:514-516.
3. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Pereztur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature 1996;383:710-713.
4. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, LevyLahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870.
5. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 1994;264:1336-1340.
6. Terwel D, Dewachter I, Van Leuven F. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromol Med 2002;2:151-165.
7. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller L, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-741.
8. Skovronsky DM, Zhang B, Kung MP, Kung HF, Trojanowski JQ, Lee VMY. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2000;97:7609-7614.
9. Poduslo JF, Wengenack TM, Curran GL. Targeting of Alzheimer's amyloid plaques. J Neurochem 2001;78:129.
10. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003;50:293-302.
11. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson A. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proce Natl Acad Sci USA 1999;96:14079-14084.
12. Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PCM, Mori S. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 2004;51:452-457.
13. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 2004;51:794-798.
14. Gelman BB. Iron in CNS disease. J Neuropathol Exp Neurol 1995;54:477-486.
15. Poduslo JF, Wengenack T, Curran GV, Macura S, Borowski B, Jack C, Wisniewski T, Sigurdsson E. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Aging 2002;23:1550.
16. Markesbery WR, Carney JM. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999;9:133-146.
17. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Van den Haute C, Checler F, Godaux E, Cordell B, Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999;274:6483-6492.
18. Dewachter I, Moechars D, van Dorpe J, Tesseur I, Van den Haute C, Spittaels K, Van Leuven F. Modelling Alzheimer's disease in multiple transgenic mice. Neuron Signal Transduction Alzheimer's Dis 2001;67:203-210.
19. van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van den Haute C, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 2000;157:1283-1298.
20. Kala SV, Hasinoff BB, Richardson JS. Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. Int J Neurosci 1996;86:263-269.
21. Wengenack TM, Whelan S, Curran GL, Duff KE, Poduslo JF. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 2000;101:939-944.
22. Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA. Iron: A pathological mediator of Alzheimer disease?. Dev Neurosci 2002;24:184-187.
23. Bodovitz S, Falduto MT, Frail DE, Klein WL. Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem 1995;64:307-315.
24. Leveugle B, Spik G, Perl DP, Bouras C, Fillit HM, Hof PR. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 1994;650:20-31.
25. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 1993;61:1171-1174.
26. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 2002;277:44670-44676.
27. Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev 1998;27:257-267.
28. Zubenko GS, Fair J, Stiffler JS, Hughes HB, Kaplan BB. Clinically-silent mutation in the putative iron-responsive element in exon 17 of the beta-amyloid precursor protein gene. J Neuropathol Exp Neurol 1992;51:459-463.
29. Bondy SC, Guo-Ross SX, Truong AT. Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid. Brain Res 1998;799:91-96.
30. Dhenain M, Duyckaerts C, Michot JL, Volk A, Picq JL, Boller F. Cerebral T2-weighted signal decrease during aging in the mouse lemur primate reflects iron accumulation. Neurobiol Aging 1998;19:65-69.
31. Gilissen EP, Jacobs RE, Allman JM. Magnetic resonance microscopy of iron in the basal forebrain cholinergic structures of the aged mouse lemur. J Neurol Sci 1999;168:21-27.
32. Aoki S, Okada Y, Nishimura K, Barkovich AJ, Kjos BO, Brasch RC, Norman D. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. Radiology 1989;172:381-385.
33. 2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992;27:368-374.
34. Gelman N, Ewing JR, Gorell JM, Spickler EM, Solomon EG. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med 2001;45:71-79.
35. Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T-2*- weighted MR microscopic images. NMR Biomed 2002;15:197-203.
36. Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M. Cerebral hemorrhage after passive anti-A beta immunotherapy. Science 2002;298:1379.
37. Morris GM, Kerwin JM, Edwardson JA. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 1994;3:267-275.